Glypican-3 Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma (HEP-10-1020)

Hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in the world. Therapeutic outcomes of HCC remain unsatisfactory, and novel treatments are urgently needed. GPC3 is an emerging target for HCC given the findings that: 1) GPC3 is highly expressed in more than 70% o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hepatology
Auteurs principaux: Fu, Ying, Urban, Daniel J., Nani, Roger R., Zhang, Yi-Fan, Li, Nan, Fu, Haiying, Shah, Hamzah, Gorka, Alexander P., Guha, Rajarshi, Chen, Lu, Hall, Matthew D, Schnermann, Martin J., Ho, Mitchell
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482108/
https://ncbi.nlm.nih.gov/pubmed/30353932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.30326
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires